References
- Staneková Z, Varecková A. Conserved epitopes of influenza A virus inducing protective immunity and their prospecs for universal vaccine development. Virol. J.7, 351 (2010).
- Ekiert DC, Bhabha G, Elsiger M-A et al. Antibody recognition of a highly conserved influenza virus epitope. Science324, 246–251 (2009).
- Knossow M, Skehel JJ. Variation and infectivity neutralization in influenza. Immunology119, 1–7 (2006).
- Wang TT, Tan GS, Hai R et al. Vaccination with a synthetic peptide from the influenza virus hemagglutinin provides protection against distinct viral subtypes. Proc. Natl Acad. Sci. USA107, 18979–18984 (2010).
- Wei C-J, Boyington JC, McTamney PM et al. Induction of broadly neutralizing H1N1 influenza antibodies by vaccination. Science329(5995), 1060–1064 (2010).
- Ekiert DC, Friesen RHE, Bhabha G et al. A highly conserved neutralising epitope on group 2 influenza A viruses. Science333(6044), 843–850 (2011).
- Corti D, Voss J, Gamblin SJ et al. A neutralizing antibody selected from plasma cells that binds to group 1 and 2 influenza A hemagglutinins. Science333(6044), 850–856 (2011).
- Roose K, Fiers W, Saelens X. Pandemic preparedness: toward a universal influenza vaccine. Drug News Prospect.22(2), 80–92 (2009).
- El Bakkouri K, Descamps F, De Filette M et al. Universal vaccine based on ectodomain of the matrix protein 2 of influenza A: Fc receptors and alveolar macrophages mediate protection. J. Immunol.186, 1022–1031 (2011).
- Neirynck S, Deroo T, Saelens X, Vanlandschoot P, Jou WM, Fiers W. A universal influenza A vaccine based on the extracellular domain of the M2 protein. Nat. Med.5, 1157–1163 (1999).
- Kreijtz JH, de Mutsert G, van Ballen CA, Fouchier RA, Osterhaus AD, Rimmelzwaan GF. Cross recognition of avian H5N1 influenza virus by human cytotoxic T-lymphocyte populations directed to human influenza A virus. J. Virol.82, 5161–5166 (2008).
- Eichelberger M, Golding H, Hess M et al. FDA/NIH/WHO public workshop on immune correlates of protection against influenza A viruses in support of pandemic vaccine development. Vaccine26, 4299–4303 (2008).
- Weaver EA, Rubrum AM, Webby RJ, Barry MA. Protection against divergent influenza H1N1 virus by a centralized influenza hemagglutinin. PLoS One6, e18314 (2011).
- Alexander J, Bilsel P, del Guercio M-F et al. Identification of broad binding class I HLA supertype epitopes to provide universal coverage of influenza A virus. Hum. Immunol.71, 468–474 (2010).
- Johnston MI, Fauci AS. An HIV vaccine – evolving concepts. N. Engl. J. Med.356, 2073–2081 (2007).